Host defense peptides clavanins A and MO reduce in vitro osteoclastogenesis
Amorim, Ingrid Aquino; Lima, Stella Maris de Freitas; Cantuária, Ana Paula de Castro; Freire, Mirna de Souza; Almeida, Jeeser Alves de; Franco, Octávio Luiz; Rezende, Taia Maria Berto.
Braz. j. oral sci
; 20: e211512, jan.-dez. 2021. ilus
Artículo
en Inglés
| BBO - odontología (Brasil), LILACS | ID: biblio-1254424
Aim:
Several systemic diseases, such as periodontitis and apical periodontitis, can cause extensive bone resorption. Host defense peptides may have the potential for the development of novel therapies for the bone resorption process. This study evaluated the potential of host defense peptides clavanins A, MO, and LL-37 in in vitro osteoclastogenesis.Methods:
RAW 264.7 cultures were stimulated with recombinant of receptor activator of nuclear factor kappa B ligand in the presence of different tested concentrations of host defense peptides, besides calcium hydroxide and doxycycline. Cellular viability, nitric oxide production, and a number of differentiated osteoclast-like cells were also evaluated.Results:
Results showed that none of the substances were cytotoxic, except for 128 µg.mL-1 of doxycycline after 3 days. Host defense peptides, calcium hydroxide, and doxycycline did not interfere in nitric oxide production or downregulated it. An exception was observed in the presence of 2 µg.mL-1 of doxycycline, in which nitric oxide production was up-regulated. All host defense peptides were capable of reducing osteoclast-like cell differentiation.Conclusion:
Host defense peptides clavanins A and MO demonstrated to be potential suppressors of osteoclastogenesis in vitro without interfering in cellular viability and nitric oxide production. These promising results need to be further analyzed in in vivo models of bone resorption
Biblioteca responsable:
BR218.1
Texto completo